PDGFRB and pulmonary arterial hypertension: Mutations in BMPR2 lead to PAH which is characterized by abnormal proliferation of ECs and smooth muscle cells (SMCs) in arterioles [73, 77], whereas a deletion of BMPR2 leads to insufficient recruitment and decreases PDGFRβ expression in mural cells [77].